Economic evaluation comparing two cervical screening strategies in Belgium: HPV primary versus co-testing
Our recent research comparing two hypothetical cervical screening algorithms in Belgium, has been accepted for publication in the European Journal of Cancer Prevention and is now available online as a preprint in medRxiv. In the study, we performed a cost-consequence analysis to evaluate the financial implications and potential benefits of two different screening protocols: 1) Read More >
Research in Dravet syndrome and cervical cancer screening presented at international conferences
Aquarius has recently presented posters at international conferences (ISPOR, a conference for the leading professional society for health economics and outcomes research and EUROGIN, an international multidisciplinary HPV conference), exploring the impact of improving healthcare for two very different conditions: Dravet syndrome (rare debilitating epilepsy) and cervical cancer. Read More >
Is it cost effective to screen women for syphilis twice during pregnancy?
The UK National Screening Committee (UK NSC) asked Aquarius to assess the costs and benefits of two different approaches to antenatal screening for syphilis. We compared the current strategy – screening in the first trimester only – with an alternative strategy – screening in the first trimester and a repeat screen later in pregnancy. The Read More >
How can economic models inform decision-making about screening programmes?
Dr Elisabeth Adams, Managing Director and Founder of Aquarius Population Health, spoke at a continuing medical education webinar for health professionals hosted on September 23,2020 by the Consortium for Infectious Disease Control (CIDC). With increasing demands on time and resources, decision-makers in healthcare need information about how to create a safe, effective and cost-effective Read More >
Aquarius part of collaborative NIHR grant to evaluate Odin Vision’s artificial intelligence technology to fight bowel cancer
In the UK, 42,000 new diagnoses and 16,000 deaths occur from bowel cancer each year. Bowel cancer is the second most common cause of cancer death in the UK, comprising over 10% of all deaths due to cancer. (1) A recent study found that almost one third of bowel cancer patients experience an avoidable delay Read More >
Assessing the impact of point-of-care testing for influenza and RSV in children admitted to hospital
The winter flu season brings added pressure to emergency and acute hospital services. In the UK, children and infants account for more than a third of flu related hospital admissions since flu and respiratory syncytial viruses (RSV) can be particularly severe in children, particularly those with existing conditions such as asthma. In our recent paper Read More >
Aquarius supports the Royal Marsden as they assess an innovative device for breast cancer surgery
In the latest episode of the BBC’s show, “Trust me, I’m a Doctor”, an innovative new product called Magseed is being trialled to improve surgery for women with breast cancer. A tiny magnetic seed is being used to transform how cancerous tissue is localised so that it can be removed, rather than using traditional guide Read More >
Digital health, health economics and Zombies!
What do digital health, health economics, making better decisions, and zombies have in common? Much more than you think! We recently attended the the Digital Art of the Possible 2 (DAP2) event hosted by the West of England Academic Health Science Network (WEAHSN) with our good friend, Charles Lowe, from the Digital Health and Care Alliance . At Read More >
PRESS RELEASE: Aquarius Population Health wins a prestigious SBRI grant from Innovate UK
Work has begun to develop a digital value proposition tool for a novel rapid sexually transmitted infection (STI) test London, UK, 14 August 2017 Aquarius Population Health, a leading independent health economics consultancy, has recently been awarded an 18-month Innovate UK grant in collaboration with Atlas Genetics Ltd and the Applied Diagnostic Research and Evaluation Read More >
Evaluating multi-bug point-of-care tests for sexually transmitted infections
We were a collaborator on a recent Innovate UK-funded SBRI project with Binx and the Applied Diagnostic Research and Evaluation Unit at St George’s University of London. In this project, our team compared the overall costs, patient benefits and cost-effectiveness of three different multi-pathogen point-of-care testing strategies with the current strategy of microscopy and lab-based Read More >